Navigation Links
Amylin and Takeda Announce Decision to Advance Development of Pramlintide/Metreleptin Combination Treatment for Obesity
Date:2/22/2010

s an enormous unmet need to help reduce the individual and economic burden of obesity," said Christian Weyer, M.D., vice president, medical development at Amylin Pharmaceuticals. "Through our global co-development and commercialization agreement with Takeda, we are committed to developing innovative therapies to help the millions of people who need better solutions to manage obesity. Today's announcement is an important step forward in helping us make good on that commitment."

"We are pleased with the results of the Phase 2 extension study for the pramlintide/metreleptin combination therapy," said Nancy Joseph-Ridge, M.D., general manager of Takeda's Pharmaceutical Development Division. "This potential new therapy continues to build on our commitment to the management of obesity."

In this extension of a 28-week Phase 2 dose-ranging study, patients who continued treatment with pramlintide/metreleptin for a total of 52 weeks demonstrated sustained weight loss, whereas those continuing on placebo regained almost all of their weight. Consistent with results at 28 weeks, the most robust efficacy was seen in patients with a body mass index (BMI) less than 35 kg/m2.

The combination therapy appeared to be generally well tolerated through 52 weeks, with nausea and injection site adve
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Amylin Pharmaceuticals to Webcast Year-End Financial Results
2. Amylin Highlights 2010 Corporate Priorities at J.P. Morgan Healthcare Conference
3. Amylin Pharmaceuticals to Present at the 18th Annual Credit Suisse Healthcare Conference
4. Amylin Pharmaceuticals and Eli Lilly and Company Statement on FDAs BYETTA(R) (Exenatide) Injection Update
5. Amylin Pharmaceuticals Reports Third Quarter Financial Results
6. Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009
7. Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
8. Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society
9. Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity
10. Takeda Announces Initiation of Trial to Study the Concomitant Use of Dexlansoprazole and Other Proton Pump Inhibitors with Plavix(R) (clopidogrel bisulfate)
11. Emerging Agents from Theravance/Astellas, Johnson & Johnson/Basilea and Forest/Astrazeneca/Takeda Will Drive Modest Growth in the MRSA Drug Market Through 2018
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... 2015 With increasing clinical applications, the ... rise in active partnerships. The primary reason for ... quantitate CD4 cell markers in human immunodeficiency virus ... New analysis from Frost ... Market ( http://www.frost.com/nf0e ), finds the market earned ...
(Date:8/31/2015)... The Wolf Administration today announced 289 drug ... State Police and local police departments have ... Heroin and opioid overdose are the leading cause of ... more individuals than those involved in fatal motor vehicle ... drug overdose. " Pennsylvania ...
(Date:8/31/2015)... 31, 2015  The departments of Drug and Alcohol ... Gaudenzia Concept 90 to raise awareness for International Overdose ... Pennsylvania and help more Pennsylvanians ... recovery through the Building Bridges to Recovery ... every day to a disease that is fully treatable, ...
Breaking Medicine Technology:Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 2Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 3Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 4Departments of Drug & Alcohol Programs and Health Announce Report 289 Pennsylvanian Lives Saved by Naloxone 2Departments of Drug & Alcohol Programs and Health Announce Report 289 Pennsylvanian Lives Saved by Naloxone 3Pennsylvania Departments of Drug & Alcohol Programs and Health Kick-off Second Annual Building Bridges to Recovery Initiative 2
... Although 2010 brought healthcare reform, investors are wondering ... likely expect some volatility in the sector, as the ... either through a repeal effort or withholding funding for ... & Poor,s Equity Research. "Healthcare reform ...
... BOTHELL, Wash., Jan. 13, 2011 SCOLR Pharma, Inc. (OTCQB: ... begin trading in the over-the counter (OTC) market beginning January ... is expected to be quoted on the OTC Bulletin Board ... cease trading on the NYSE Amex Exchange at the close ...
Cached Medicine Technology:S&P Equity Research Issues Health Care Sector Predictions for 2011 2S&P Equity Research Issues Health Care Sector Predictions for 2011 3S&P Equity Research Issues Health Care Sector Predictions for 2011 4S&P Equity Research Issues Health Care Sector Predictions for 2011 5S&P Equity Research Issues Health Care Sector Predictions for 2011 6SCOLR Pharma, Inc. Common Stock to Begin Trading on OTC Bulletin Board and OTCQB Stock Market on January 13, 2011 2
(Date:9/1/2015)... Francisco, Calif. (PRWEB) , ... September 01, 2015 ... ... to corporations, law firms and government entities, announced today that it has hired ... Senior Discovery Consultant. In this capacity, Sanderson will be responsible for establishing ...
(Date:9/1/2015)... ... September 01, 2015 , ... Royal River Natural Foods, a locally-owned independent natural ... women for 19 years and found that, among those who had a stroke, people ... report is part of the September 2015 issue of “Natural Insights for Well Being,” ...
(Date:9/1/2015)... , ... September 01, 2015 , ... ... Brent Nelson, D.O., has joined its medical management team as an Associate Medical ... of all sizes and types in the U.S. and abroad. , Dr. ...
(Date:9/1/2015)... ... September 01, 2015 , ... Two of Washington D.C.’s most ... through food and dining. , Recently named “the next big thing” in the ... known for telling the whole story behind food and reclaiming culinary traditions on the ...
(Date:9/1/2015)... ... 01, 2015 , ... SC&H Group, a leading audit, tax, and consulting firm, ... of the Best” firm in the U.S., as well as being ranked a Top ... in the U.S., selected exclusively on performance in specific areas of financial and operational ...
Breaking Medicine News(10 mins):Health News:Former NFL Standout Scott Sanderson Joins eDiscovery Leader Discovia 2Health News:New Study Finds Multivitamins Extend Life After Stroke, Retailer Reports 2Health News:Dr. Brent Nelson Joins WorkCare, Inc., as Associate Medical Director 2Health News:Dr. Brent Nelson Joins WorkCare, Inc., as Associate Medical Director 3Health News:Chefs Amy Riolo and Luigi Diotaiuti Embark on Culinary Diplomatic Quest to Build Bridges through Global Cuisine 2Health News:Chefs Amy Riolo and Luigi Diotaiuti Embark on Culinary Diplomatic Quest to Build Bridges through Global Cuisine 3Health News:Chefs Amy Riolo and Luigi Diotaiuti Embark on Culinary Diplomatic Quest to Build Bridges through Global Cuisine 4Health News:SC&H Group Receives Multiple Honors from INSIDE Public Accounting 2
... infection with a reduced susceptibility to the potent antibiotic drug ... Ford Hospital study. Researchers found that patients who contracted ... hospital longer, were more likely to have the infection return ... from it after 90 days than patients who do not ...
... (Toronto) Mental illness is associated with more lost work ... $51 billion annually in lost productivity. In the first study ... Mental Health (CAMH) have calculated the actual cost of mental ... cost of a leave for a physical illness. ...
... A drug developed at the University of Kansas has ... often leads to pain in the extremities and even amputations, ... article showing that KU-32 can stop and even reverse diabetic ... death of nerves in the extremities of individuals with diabetes. ...
... Karen Pallarito HealthDay Reporter , THURSDAY, Sept. ... through large, employer-sponsored health plans will see a number ... paying more for that coverage, employers and benefits consultants ... and higher contributions from the individual members of the ...
... health decision-makers need to collaborate in a more efficient ... of supply shortages for pediatric vaccines but also to ... coverage, according to research published by a University of ... Sheldon H. Jacobson, a professor of computer science ...
... issue of the Hastings Center Report ... state to legalize physician-assistance in dying, either do not ... such assistance. Both legal and moral reasons are identified. ... important for assuring that physician-assisted death is carried out ...
Cached Medicine News:Health News:Henry Ford Hospital study: hVISA linked to high mortality 2Health News:Mental health leaves most costly disability to Canadian employers 2Health News:Drug holds promise to halt debilitating condition of diabetes 2Health News:Drug holds promise to halt debilitating condition of diabetes 3Health News:Health Care Reform: Employees Face Greater Cost-Sharing 2Health News:Health Care Reform: Employees Face Greater Cost-Sharing 3Health News:Health Care Reform: Employees Face Greater Cost-Sharing 4Health News:Pediatric vaccine stockpile policies need to be revisited, researcher says 2Health News:Pediatric vaccine stockpile policies need to be revisited, researcher says 3Health News:Study finds most Oregon hospices do not fully participate in the Death with Dignity Act 2
The CH 2000 Cardiac Diagnostic system is a fully featured stress testing system that can include Microvolt T-Wave Alternans (MTWA) testing capability as an add-on feature. , ,Interfaces with Tra...
... The Volk G-1 trabeculum provides the highest ... Perfect for viewing and treating the trabecular meshwork. ... of the anterior chamber angle while the central ... view the posterior pole for signs of glaucoma ...
... AFX (Air Fluid eXchange) Lens ... designed for use in an ... its use as a primary ... low profile and sutureless design ...
... The 45° Prism is ... pathologies and are recommended ... (PDR, BRVO etc.) and ... can be used for ...
Medicine Products: